Guangzhou Ruitai Biotechnology Co.
Latest round
- Series A
Last raised
- Mar 2023
Total raised
- $14M
Investors
- 4
About Guangzhou Ruitai Biotechnology Co.
, Ltd. operates as a high-tech enterprise specializing in the research and development, production and sales of regenerative repair materials and its related medical device products. The company completed the development and clinical work of biological amniotic membrane products for ophthalmology in 2018, obtained the Registration Certificate of Medical Devices of the People's Republic of China issued by the State Drug Administration in 2019, and obtained the Medical Device Manufacturing License in 2020. Hao Xu, the founder of the company, has served as the head of ophthalmology sales for companies such as Merck, Pfizer, and Shenzhen Ruilin Medicine. The company independently developed the wet biological amniotic membrane (Rixiufu®), which is an active biological material that can solve various ophthalmic diseases from the ocular surface to the fundus. It is mainly used in ocular surface reconstruction and more than 200 hosipitals. The company has a rich pipeline of research and development, and the products are covering ocular surface damage, dry eye, glaucoma, fundus macular hole, optometry and other fields.
Who invested in Guangzhou Ruitai Biotechnology Co.
4 investors across 2 rounds
See all investors in Guangzhou Ruitai Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Guangzhou Ruitai Biotechnology Co.
Who invested in Guangzhou Ruitai Biotechnology Co.?
Guangzhou Ruitai Biotechnology Co. has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Guangzhou Ruitai Biotechnology Co. raised?
Guangzhou Ruitai Biotechnology Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Guangzhou Ruitai Biotechnology Co. last raise money?
Guangzhou Ruitai Biotechnology Co.'s most recent round on record is a Series A, in Mar 2023.
What does Guangzhou Ruitai Biotechnology Co. do?
Guangzhou Ruitai Biotechnology Co. is a medical devices & equipment company.
Where is Guangzhou Ruitai Biotechnology Co. headquartered?
Guangzhou Ruitai Biotechnology Co. is headquartered in Guangzhou, China.
Which VCs invest in companies like Guangzhou Ruitai Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Guangzhou Ruitai Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Guangzhou Ruitai Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.